Legislation to establish Prescription Drug Affordability Board in Michigan has widespread support
LANSING, Mich. (Oct. 04, 2023) — Today, the Michigan Senate passed Senate Bills 483–485. The bills, sponsored by Sens. Darrin Camilleri (D-Trenton), Kristen McDonald Rivet (D-Bay City) and Veronica Klinefelt (D-Eastpointe), will create an independent Prescription Drug Affordability Board (PDAB) in Michigan — as well as ensure medical service providers, insurance companies and Medicaid comply with the new legislation — to help lower prescription drug costs for all consumers.
“Too many people in our state are having to choose between affording food and the medication they need. This is an issue that’s only getting worse, and it’s time to act,” said Sen. Camilleri. “With today’s passage in the Senate, we’re one critical step closer to establishing a Prescription Drug Affordability Board and ensuring equitable access to vital medications for every Michigander.”
With the ability to set Upper Payment Limits on the most expensive prescription drugs, PDAB will play a critical role in identifying cost-saving opportunities. The Board would bring accountability, oversight and transparency to the prescription drug industry. Its recommendations will serve as a valuable resource for residents, patients, medical professionals and policymakers.
“Too many Michiganders are priced out of their own health,” said Senate Majority Leader Winnie Brinks (D-Grand Rapids). “It can be challenging enough to deal with a life-changing diagnosis and adding enormous medication bills on top of that stress can be unbearable. Today, we’re taking action to change that. The Prescription Drug Affordability Board can make the system work better for everyone and reduce financial barriers to wellness. We’re proud to vote ‘yes’ on a measure that will make our state a more affordable place to live and thrive.”
The PDAB represents a crucial step forward in the fight against rising prescription drug costs in Michigan. The board has the potential to make a lasting and positive impact on the lives of Michiganders, ensuring that they can afford their medications without sacrificing their financial stability or compromising their health. A PDAB in Michigan has significant support from advocates — including medical professionals and associations, policy experts and patients, to name a few. The coalition of support highlights the importance for immediate intervention to alleviate the financial strain imposed by high prescription drug costs and promote equitable healthcare opportunities.
###